Scarica l'app Stockscreener
4.97
1.02%
0.05
Dopo l'orario di chiusura:
4.96
-0.010
-0.20%
Precedente Chiudi:
$4.92
Aprire:
$4.92
Volume 24 ore:
446.73K
Relative Volume:
0.95
Capitalizzazione di mercato:
$268.39M
Reddito:
-
Utile/perdita netta:
$-86.60M
Rapporto P/E:
-1.7547
EPS:
-2.8324
Flusso di cassa netto:
$-67.37M
1 W Prestazione:
+4.41%
1M Prestazione:
+4.19%
6M Prestazione:
+98.80%
1 anno Prestazione:
-55.62%
Intervallo 1D:
$4.86
$5.06
Intervallo di 1 settimana:
$4.64
$5.06
Portata 52W:
$1.45
$11.72
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
Nome
Lexeo Therapeutics Inc
Settore
Industria
Telefono
(212) 547-9879
Indirizzo
345 PARK AVENUE SOUTH, NEW YORK
Confronta LXEO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LXEO
Lexeo Therapeutics Inc
|
4.97 | 258.67M | 0 | -86.60M | -67.37M | -2.8324 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-31 | Iniziato | Oppenheimer | Outperform |
| 2024-06-13 | Iniziato | Robert W. Baird | Outperform |
| 2024-06-06 | Iniziato | H.C. Wainwright | Buy |
| 2023-11-28 | Iniziato | Chardan Capital Markets | Buy |
| 2023-11-28 | Iniziato | JP Morgan | Overweight |
| 2023-11-28 | Iniziato | Leerink Partners | Outperform |
| 2023-11-28 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-11-28 | Iniziato | Stifel | Buy |
Mostra tutto
Lexeo Therapeutics Inc Borsa (LXEO) Ultime notizie
Stifel Maintains Buy Rating on Lexeo Therapeutics (LXEO) - MSN
Visualizing Lexeo Therapeutics Inc. stock with heatmapsJuly 2025 Action & Free Long-Term Investment Growth Plans - Newser
How to manage a losing position in Lexeo Therapeutics Inc.Watch List & Weekly Breakout Stock Alerts - Newser
How to recover losses in Lexeo Therapeutics Inc. stockWeekly Trade Recap & Scalable Portfolio Growth Methods - Newser
What high frequency data says about Lexeo Therapeutics Inc.Quarterly Trade Report & High Win Rate Trade Tips - Newser
Lexeo Therapeutics Inc. stock trend outlook and recovery pathMarket Risk Summary & Proven Capital Preservation Methods - Newser
Real time alert setup for Lexeo Therapeutics Inc. performance2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - Newser
Institutional scanner results for Lexeo Therapeutics Inc.Portfolio Gains Summary & Fast Gain Swing Trade Alerts - Newser
Bear Alert: Is Lexeo Therapeutics Inc. affected by consumer sentimentProduct Launch & Weekly High Momentum Picks - khodrobank.com
Analyzing Lexeo Therapeutics Inc. with multi timeframe charts2025 Year in Review & Free Community Consensus Stock Picks - Newser
Is Lexeo Therapeutics Inc. stock a value trapMarket Trend Review & Growth Focused Stock Pick Reports - khodrobank.com
Lexeo Therapeutics Inc. stock momentum explainedGlobal Markets & AI Forecast for Swing Trade Picks - Newser
How does Lexeo Therapeutics Inc. compare to its peers2025 Performance Recap & Breakout Confirmation Trade Signals - khodrobank.com
How sentiment analysis helps forecast Lexeo Therapeutics Inc.2025 EndofYear Setup & Safe Entry Zone Tips - Newser
Can Lexeo Therapeutics Inc. withstand a market correctionQuarterly Trade Report & Fast Exit and Entry Strategy Plans - khodrobank.com
Historical volatility pattern of Lexeo Therapeutics Inc. visualized2025 Stock Rankings & Scalable Portfolio Growth Ideas - Newser
Identifying reversal signals in Lexeo Therapeutics Inc.Market Volume Summary & Low Drawdown Momentum Trade Ideas - Newser
Can trapped investors hope for a rebound in Lexeo Therapeutics Inc.Weekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
Strategies to average down on Lexeo Therapeutics Inc.Earnings Beat & Risk Managed Investment Entry Signals - Newser
Is now the right time to enter Lexeo Therapeutics Inc.Market Risk Report & Fast Exit/Entry Strategy Plans - khodrobank.com
Is Lexeo Therapeutics Inc. currently under institutional pressure2025 Market WrapUp & Precise Swing Trade Entry Alerts - khodrobank.com
Published on: 2025-09-01 15:48:56 - Newser
Can Lexeo Therapeutics Inc. reach all time highs this yearTrade Exit Report & AI Optimized Trade Strategies - khodrobank.com
Why is Lexeo Therapeutics Inc. stock going up2025 Macro Impact & Weekly Return Optimization Plans - khodrobank.com
What’s next for Lexeo Therapeutics Inc. stock priceJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - Newser
Should value investors consider Lexeo Therapeutics Inc.2025 Stock Rankings & Momentum Based Trading Ideas - khodrobank.com
What data driven models say about Lexeo Therapeutics Inc.’s futureWeekly Volume Report & Short-Term High Return Strategies - Newser
Technical Charts Suggest Momentum Shift in Lexeo Therapeutics Inc.2025 Price Action Summary & Weekly Momentum Stock Picks - beatles.ru
How to interpret RSI for Lexeo Therapeutics Inc. stockOil Prices & High Return Trade Opportunity Guides - Newser
Price momentum metrics for Lexeo Therapeutics Inc. explainedJuly 2025 Trends & Stock Portfolio Risk Management - Newser
Published on: 2025-08-31 15:36:57 - Newser
Using R and stats models for Lexeo Therapeutics Inc. forecasting2025 Earnings Surprises & Verified High Yield Trade Plans - Newser
Lexeo Therapeutics Inc. Charts Flash Early Recovery Signals getLinesFromResByArray error: size == 0 - 클래시안
Is Lexeo Therapeutics Inc. affected by consumer sentimentEarnings Miss & Technical Analysis for Trade Confirmation - kpenews.com
Published on: 2025-08-30 19:02:33 - Newser
Lexeo Therapeutics Inc Azioni (LXEO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lexeo Therapeutics Inc Azioni (LXEO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Robertson Jenny | Chief Legal Officer |
Aug 18 '25 |
Sale |
4.67 |
542 |
2,530 |
62,556 |
| Adler Eric | Chief Medical Officer |
Aug 18 '25 |
Sale |
4.67 |
608 |
2,838 |
67,073 |
| Townsend Richard Nolan | Chief Executive Officer |
Aug 18 '25 |
Sale |
4.67 |
2,735 |
12,767 |
220,058 |
| See Tai Sandi | Chief Development Officer |
Aug 18 '25 |
Sale |
4.67 |
382 |
1,783 |
58,860 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):